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Abstract
Introduction: The prevalence of diabetes type 2 is increasing worldwide, thus the search of novel alternative ther-
apies is needed. According to their traditional use, we selected five Bolivian plants Chenopodium quinoa (CQ) Ama-
ranthus caudatus (AC), Chenopodium pallidicaule (CP), Lupinus mutabilis (LM) and Smallanthus sonchifolius (SS) that 
are traditionally used to control glycemia. 
Methods: The effect of a single oral administration of Ethanolic (EtOH), hydro-ethanolic (EtOH70) and aqueous (Aq) 
extracts from all plant species were tested for their effect on blood glucose in non-fasted mice and during the oral 
glucose tolerance test (OGTT). The effect on insulin secretion was evaluated in mice pancreatic islets.
Results: EtOH70 extracts of all the plants showed glucose-reducing effect at the highest dose evaluated (2000 mg/
kg b.w.). EtOH70 extracts improved the glucose tolerance evaluated by the OGTT in mice fasted for 12 hours. The 
extracts have different effects on glucose homeostasis since just extracts of AC, LM and CQ but not CP and SS in-
creased insulin secretion as shown on mice pancreatic islets. The phytochemical qualitative characterization of 
EtOH70 extracts detected phenolic acids and flavonoids in AC, CP and CQ; alkaloids in LM and anthocyanidins in SS. 
None of EtOH70 extracts tested showed in vitro or in vivo acute toxicity at concentrations where they exhibit glucose 
lowering effects. 
Conclusions: We report here that extracts from AC, CQ, CP, LM and SS exhibit glucose lowering effect while just AC, 
CQ and LM stimulate directly the insulin secretion. 
Keywords: Nutraceutical; Natural product; Insulin secretion.
Resumen
Introducción: La prevalencia de diabetes tipo 2 está aumentando en todo el mundo, por lo que se necesita la 
búsqueda de nuevas terapias alternativas. Según su uso tradicional, seleccionamos cinco plantas bolivianas Cheno-
podium quinoa (CQ) Amaranthus caudatus (AC), Chenopodium pallidicaule (CP), Lupinus mutabilis (LM) y Smallanthus 
sonchifolius (SS) que se usan tradicionalmente para controlar la glucemia.
Métodos: Se evaluó el efecto de la administración oral única de extractos etanólicos (EtOH), hidroetanólicos 
(EtOH70) y acuosos (Aq) de las plantas mencionadas para determinar su efecto sobre la glucosa en sangre en ra-
tones en o sin ayunas y durante la prueba de tolerancia a la glucosa oral (PTGO). El efecto sobre la secreción de 
insulina se evaluó en islotes pancreáticos de ratones.
Resultados: Los extractos de EtOH70 de todas las plantas disminuyeron la glucemia a la dosis más alta evaluada 
(2000 mg / kg b.w.). Los extractos de EtOH70 mejoraron la tolerancia a la glucosa evaluada mediante la PTGO en ra-
tones con ayuno de 12 horas. Los extractos tienen diferentes efectos sobre la homeostasis de la glucosa, ya que solo 
los extractos de AC, LM y CQ pero no CP y SS aumentaron la secreción de insulina como se muestra en los islotes pan-
creáticos de los murinos. La caracterización cualitativa fitoquímica de extractos de EtOH70 detectó ácidos fenólicos 
y flavonoides en AC, CP y CQ, alcaloides en LM y antocianidinas en SS. Ninguno de los extractos de EtOH70 probados 
mostró toxicidad aguda in vitro o in vivo a concentraciones en las que exhiben efectos reductores de glucosa.
Conclusión: Los extractos de AC, CQ, CP, LM y SS exhiben un efecto reductor de la glucosa, mientras que solo AC, CQ 
y LM estimulan directamente la secreción de insulina.
Palabras clave: Nutracéutico; Producto natural; Secreción de insulina.
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Introducción
The prevalence of non-communicable diseases such as metabolic syndrome, obesity, and type 2 dia-
betes mellitus (T2DM) has increased worldwide(1). One main responsible factor is the dietary change 
habits to food rich in fat, and carbohydrates(2-4). Anti-diabetic drugs are used to control blood glucose 
levels, but some of these drugs have adverse effects, including the risk of hypoglycemia(5).
Recently, the use of certain food to restore the metabolic balance has been reported(6). Nutraceuticals, 
i.e. components from food sources provide not only nutritional but also health benefits by modulating 
pathophysiological processes to get favorable health outcomes(2,7-9). This approach might be easy to be 
accepted by large number of patients and are potentially less coupled with severe secondary reactions 
compared to conventional drug therapies(2,10,11).
According to their traditional use, Bolivia has a huge diversity of food plants that could be considered 
as nutraceuticals. Thus, based on literature review, we selected five plants that are currently part of 
Bolivian diet to evaluate their property to reduce glycemia; andean pseudocereal seeds, Chenopodium 
quinoa (quinua), (CQ) Amaranthus caudatus (amaranto) (AC) and Chenopodium pallidicaule (kañawa) 
(CP), a legume, Lupinus mutabilis (tarwi) (LM) and a tuberous root Smallanthus sonchifolius (yacon) (SS). 
The pseudocereals are still the principal protein sources of the region; with similar content of essential 
amino acids(12). LM and SS have compounds with therapeutic potential, such as phenolic compounds 
and antioxidants(13,14). While LM has been reported to lower the blood glucose levels by an unclear 
mechanism(15-18), potential anti-diabetic properties were already reported for CQ that inhibits the α-glu-
cosidase enzyme(19) and for AC that inhibits the α-amylase(17,20). On the other hand, SS is an alternative 
food for patients with conditions that require dietary changes(13,21).
The present study evaluated the glycemia-reducing properties of extracts from AC, CQ, CP and LM seeds 
and the SS root in an experimental murine mouse model and investigated their effects on insulin secretion.
Methods
Animals
Male Swiss albino mice, weighing 20 ± 5 g were purchased from the Animal Facility of the Facultad 
de Ciencias Farmacéuticas y Bioquímicas, Universidad Mayor de San Andrés. Experiments were per-
formed after one week of adaptation in the experimentation unit. Animals were kept at 22 °C with alter-
nating 12 h light- dark cycle and had free access to food and fresh water. The study has ethical approval 
CEI-UMSA 0115 from the Ethics Committee of the Universidad Mayor de San Andrés(17,18).
Plant Species
Plant species were collected from local producers in Bolivia. AC, from Tomina municipality, Tomina 
Province, Chuquisaca (latitude 19°25´53.96´´S and longitude 64°15´5.44´´W). CQ and CP from Huan-
cane (latitude 16°18´14.14´´S and longitude 68°32´35.88´´W) and Peñas (latitude 16°13´55.02´´S 
and longitude 68°29´41.70´´W) locality, respectively, Batallas municipality, Los Andes Province, La 
Paz. LM from Ancoraimes municipality, Omasuyos Province, La Paz (latitude 15°55´19.3´´S and longi-
tude 68°53´50.1´´W). SS from Sorata municipality, Laracaja Province, La Paz (latitude 15°45´12.18´´S 
and longitude 68°39´19.46´´W). One voucher specimen of each plant, AC (No. EG-1, Amaranthaceae), 
CQ (No. EG-2, Amaranthaceae), CP (No. EG-3, Amaranthaceae), LM (No. EG-1, Fabaceae) and SS (No. 
EG-1, Asteraceae) was identified and certified by the Herbario Nacional de Bolivia from Universidad 
Mayor de San Andrés and has been deposited at the Department of Pharmacology at the Instituto de 
Investigaciones Farmaco Bioquímicas, UMSA, La Paz, Bolivia(17,18).
Plant Extracts Preparation
200 g of AC, CP, CQ and LM, seeds were powdered and macerated during 48 h in absolute ethanol (EtOH 
extract), 70% ethanol solution (EtOH70 extract) or water (Aq extract) (250 ml). To maximize the yield, 
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the maceration procedure was repeated 2 times for Aq extracts and 5 times for EtOH and EtOH70 ex-
tracts. SS, was prepared with 50 g of dry roots macerated during 48 h in 1000 ml of each solvent, previ-
ously mentioned; the maceration procedure was repeated 2 times for Aq extracts and 4 times for EtOH 
and EtOH70 extracts. Aq extracts were dried under pressure in a freeze dryer (Labconco, USA). EtOH 
and EtOH70 extracts were first concentrated by a rotary evaporator (Heidolph, Germany) and then 
dried under pressure in a freeze dryer (Labconco, USA). Crude extracts obtained had an appearance 
of a light powder with a yield of AC 6.5 % w/w, CQ 5.6% w/w, CP 5.5% w/w, LM 22.0% w/w and SS 6.0% 
w/w. For experiments, the extracts were dissolved in water and stock solutions were sterilized by a 0.22 
μm Millipore filter, prior to use(17,18). 
Phytochemical analysis
EtOH70 extracts from the studied species were screened for the presence of the phytoconstituents; 
alkaloids, tannins, phenolic compounds, flavonoids, anthocyanidins, saponins and coumarins where 
determined using standard qualitative procedures(22).
Oral Acute Toxicity
EtOH70 extracts were evaluated for their potential acute oral toxicity according to the guidelines set 
by the Organization for Economic Cooperation and Development (OECD) guideline No. 423(23). Male 
Swiss albino mice (20 ± 5 g) received one single oral dose (2000 mg/kg) of each extract. Mortality and 
general behavior of treated groups were monitored for 14 days, then blood samples were collected to 
determine hematological and biochemical parameters. 
Cytotoxicity
Cellular toxicity was evaluated in cell line BHK-21 (Hamster Kidney Fibroblast). Briefly, cells were seed-
ed in 96 wells plates at 1x105 cells/ml and were exposed to EtOH70 extracts (400 – 5 mg/ml) diluted in 
RPMI 1640 medium supplemented with antibiotics (100 IU/mL penicillin and 0.1 mg/mL streptomycin) 
(Invitrogen, USA) and heat-inactivated fetal calf serum (10%) (Sigma-Aldrich, USA). The cell viability 
was determined by MTT assay after 24 h(24,25).
Screening for glycemia-reducing effects
The effect of plant extracts on glycemia was evaluated in non-fasted mice by single oral administration 
by gavage. Several doses were tested: 4000 mg/kg and 2000 mg/kg b.w. for EtOH and Aq extracts and 
2000 mg/kg, 1000 mg/kg and 500 mg/kg b.w for EtOH70 extracts of AC, CQ, CP and LM. For SS 1000 mg/
kg b.w. for EtOH and Aq extracts and 1000 mg/kg, 500 mg/kg and 250 mg/kg b.w. for EtOH70. For experi-
mentation Aq and EtOH70 extracts were dissolved in distillated water, and EtOH were dissolved in 1.5% 
water solution of Tween 20. The placebo groups received distillated water and 1.5 % water solution of 
Tween 20. Blood samples from the tip of the tail were collected 1, 2, 4 and 6 hours, after administration 
of the extracts(17,18,26). Glycemia was measured using a glucometer (Clever Check, USA). 
Oral Glucose Tolerance Test
Active extracts in screening evaluation were further evaluated during an oral glucose tolerance test 
(OGTT). The extracts were administrated orally, one hour before the test, to 10 h fasted mice. Blood 
glucose levels were determined at 0, 15, 30, 60, and 120 minutes after the oral administration of glucose 
(3 g/kg b.w.). Several doses were tested for AC, CQ, CP and LM (2000 mg/kg, 1000 mg/kg and 500 mg/kg 
b.w) and for SS (1000 mg/kg, 500 mg/kg and 250 mg/kg b.w). The placebo group received water, and 
the positive control group received glibenclamide (0.5 mg/kg b.w.)(17,18,26).
Pancreatic Islets Isolation
Mouse pancreatic islets were isolated by collagenase digestion followed by histopaque gradient sep-
aration. Briefly, 9 mg of collagenase dissolved in 10 mL of Hank’s Balanced Solution (HBBS) were in-
jected through the bile duct to insufflate the pancreas. Then the gland was collected in a test tube and 
digested in water bath without shaking for 24 min at 37°C. After the digestion, collagenase was washed 
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away with HBSS and digested tissue was then filtrated through a strainer. Finally, islets were separated 
by centrifugation at 2000 rpm for 20 min using a mixture of Histopaque 1119 and 1077 (Sigma-Aldrich, 
USA). For overnight culture, islets were hand-picked using a stereomicroscope and then cultured at 
37°C, with an atmosphere of 5% CO2-95% air in RPMI 1640 supplemented with 30 mg L-glutamine (Sig-
ma-Aldrich, USA), 11 mM glucose (Sigma-Aldrich, USA), antibiotics (100 IU/mL penicillin and 0.1 mg/mL 
streptomycin) (Invitrogen, USA) and heat-inactivated fetal calf serum (10%) (Sigma-Aldrich, USA)(27,28,29).
Islet Insulin Secretion
Overnight cultured islets were preincubated during 30 - 45 min in Krebs-Ringer bicarbonate (KRB) buf-
fer (NaCl 118.4 mM, KCl 4.7 mM, MgSO4 1.2 mM, KH2PO4 1.2 mM, CaCl2 1.9 mM, NaHCO3 25 mM, HEPES 
10 mM and 0.2% bovine serum albumin) (Sigma-Aldrich, USA) in 3.3 mM glucose and 37°C with an 
atmosphere of 5% CO2-95% air. Batches of 3 islets of similar size were incubated during 60 min in 300 
μL of KRB in 3.3 mM or 16.7 mM glucose, with or without extracts at different concentrations (5 - 20 mg/
mL) at 37°C in a shaking water bath(27,28,29). After incubation, 200 μl of the solutions were collected to 
new tubes and kept in freezer −20°C for insulin quantification by ELISA (Thermo Fisher Scientific, USA).
Statistical Analysis
Results are presented as mean ± SEM. Statistical difference between groups was analyzed using two-
way analysis of variance (ANOVA) for screening, OGTT and insulin secretion evaluations whereas paired 
Student’s t-test was used for AUC analysis. Bonferoni’s Post Hoc Test was used for correction in multiple 
testing. A P value of less than 0.05 was considered as significant. Data were analyzed using Prism Graph 
Pad Software (CA, USA)(17,18,27).
Results
Qualitative Phytochemical screening
Qualitative phytochemical characterization of crude EtOH70 extracts indicates the presence of pheno-
lic compounds, tannins and antocianidins in all extracts (Table 1). Alkaloids were found only in LM and 
CQ extracts; flavonoids and coumarins were present in all extracts but AC. No saponins were detected 
in any of the extracts.
Table 1. Phytochemical screening. Constituents are represented according to their intensity. (-) Absent; (+) Present. 
Name of constituents AC CQ CP LM SS
Alkaloids - + - +++ -
Tannins & Phenolic compounds + +++ + + +
Flavonoids - + ++ ++ +
Anthocyanidins ++ + ++ +++ +++
Saponin - - - - -
Coumarins - ++ +++ ++ ++++
Evaluated extracts have no toxic effect
The 50% cytotoxic concentration (CC50) after 24 h of exposure evaluated by MTT assay were 208 ± 12.4 
mg/ml for AC, 210 ± 22.2 mg/ml for CQ, 180± 11.1 mg/ml for CP, 52.3 ± 3.4 mg/ml for LM and 15 ± 1.1 mg/
ml for SS. 
No mice died during the observation period of the oral acute toxicity evaluation and normal behav-
ior were noted in all treated animals. No significant differences in hematological parameters (red and 
white blood cells number, hematocrit and hemoglobin) or in biochemical indicators (aspartate trans-
aminase, alanine transaminase, uric acid, cholesterol, triglycerides) were observed (data not shown).
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Screening evaluation showed promising glycemia-reducing plant species
Single administration of extracts of pseudocereals AC, CQ and CP lowered the levels of glycemia in mice 
(Table 2).
Table 2. The effect of single oral administration of pseudocereals AC, CP and CQ extracts on glycemia in non-fasted 
mice (n=10)
Time (h) 0 1 2 4 6
AC EtOH70 extract (mg/kg b.w.)
2000 9.5±0.4 8.6±0.5# 7.8±0.3*### 7.0±0.3***#### 6.9±0.5****####
1000 9.2±0.2 9.0±0.3 9.0±0.5# 8.8±0.6 8.6±0.5
500 9.5±0.2 10.0±0.6 8.8±0.5 8.3±0.5# 8.2±0.2
AC Aq extract (mg/kg b.w.)
4000 9.5±0.7 9.2±0.7 9.5±0.5 9.7±0.6 9.2±0.6
2000 9.6±0.8 9.4±0.8 9.6±0.6 9.8±0.5 9.3±0.6
AC EtOH extract (mg/kg b.w.)
4000 10.5±0.6 9.1±0.8 9.0±0.7 6.6±0.5 8.4±0.2****####
2000 11.1±0.9 10.8±0.9 11.1±0.7 11.3±0.6 10.7±0.7
CQ EtOH70 extract (mg/kg b.w.)
2000 10.0±0.2 9.3±0.2 8.9±0.1# 8.7±0.3# 9.3±0.3
1000 8.2±0.8 9.2±1 8.9±0.9# 8.4±0.9# 7.9±0.8
500 9.1±0.3 10.4±0.4 9.7±0.2 9.3±0.3 8.5±0.3
CQ Aq extract (mg/kg b.w.)
4000 9.0±0.3 8.5±0.3## 8.8±0.3## 9.2±0.3 8.9±0.2
2000 8.8±0.3 8.9±0.3# 9.5±0.3 9.3±0.4 9.1±0.3
CQ EtOH extract (mg/kg b.w.)
4000 11.1±0.5 10.0±0.3 9.2±0.2**# 9.5±0.3* 9.7±0.3*
2000 10.5±0.2 9.7±0.3 9.4±0.2 8.6±0.3**# 9.5±0.4
CP EtOH70 extract (mg/kg b.w.)
2000 9.7±0.2 9.2±0.1# 9.0±0.2# 8.9±0.2# 9.1±0.3
1000 10.0±0.3 9.9±0.1 10.3±0.4 9.0±0.2 8.9±0.4
500 10.0±0.2 9.4±0.2 9.9±0.1 9.3±0.1 9.0±0.3
CP Aq extract (mg/kg b.w.)
4000 9.3±0.3 9.1±0.1 9.4±0.2 9.9±0.3 9.1±0.1
2000 10.2±0.7 9.7±0.5 9.8±0.3 9.5±0.4 9.6±0.5
CP EtOH extract (mg/kg b.w.)
4000 8.7±0.2 8.3±0.3## 8.1±0.2### 7.9±0.2## 7.8±0.1##




10,7±0.3 10,4±0.2 10,2±0.3 10±0.4 9,6±0.4
H2O 10.2±0.2 10.1±0.3 10.4±0.5 9.9±0.6 9.5±0.6
Data are presented as means ± SE (n = 10). *p< 0.05, ** p<0.01, *** p<0.001, **** p<0.0001 compared to time 0; # p<0.05, 
## p<0.01, ### p<0.001, #### p<0.0001 compared to placebo group at the same time point. 
LM EtOH70 extract reduced glycemia 2 - 6 h after treatment in a dose-dependent manner (Table 3). 
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Table 3. The effect of single oral administration of LM extracts on glycemia in non-fasted mice (n=10)
Time (h) 0 1 2 4 6
LM EtOH70 extract (mg/kg b.w.)
2000 9.0±0.6 8.0±0.4# 7.7±0.6## 7.2±0.8### 7.1±0.4*##
1000 9.8±0.6 9.2±0.6 8.2±0.6## 6.4±0.5****#### 6.9±0.3***##
500 10.3±0.3 10.0±0.4 9.4±0.4 8.2±0.6* 7.2±0.5***##
LM Aq extract (mg/kg b.w.)
4000 10.0±0.7 9.7±0.6 9.6±0.5 9.9±0.5 9.2±0.6
2000 9.7±0.2 9.5±0.2 9.5±0.5 9.3±0.5 9.3±0.3
LM EtOH extract (mg/kg b.w.)
4000 9.8±0.3 10.1±0.5 8.8±0.3 8.7±0.4 8.1±0.5
2000 10.0±0.8 9.8±0.8 10.0±0.7 10.2±0.5 9.7±0.6
Placebo
1,5% Tween 20 10,7±0.3 10,4±0.2 10,2±0.3 10±0.4 9,6±0.4
H2O 10.2±0.2 10.1±0.3 10.4±0.5 9.9±0.6 9.5±0.6
Data are presented as means ± SE (n = 10). *p< 0.05, ** p<0.01, *** p<0.001, **** p<0.0001 compared to time 0; # p<0.05, 
## p<0.01, ### p<0.001, #### p<0.0001 compared to placebo group at the same time point. 
No effect was observed in groups treated with LM EtOH and LM Aq extracts. SS EtOH70 extract (1000 
mg/kg b.w.) reduced glycemia 2 - 4 h after treatment (Table 4). No effect was observed in groups treated 
with SS EtOH and Aq extracts.
Table 4. The effect of single oral administration of SS extracts on glycemia in non-fasted mice (n=10). 
Time (h) 0 1 2 4 6
SS EtOH70 extract (mg/kg b.w.)
1000 12.4±0.3 10.9±0.4 10.1±0,3** 8.7±0.4****# 10.7±0.6
500 12.4±0.6 10.7±0.5 9.3±0.5***## 9.7±0.8** 10.3±0.4*
250 12.6±0.5 11.6±0.7 10.1±0.4# 9.9±0.2 10.2±0.5
SS Aq extract (mg/kg b.w.)
1000 11.6±0.4 10.2±0.7 10.1±0.3 8.9±0.7 9.7±0.5
SS EtOH extract (mg/kg b.w.)
1000 11.6±0.8 10.4±0.5 9.2±0.4 8.6±0.6 9.6±0.5
Placebo
1,5% Tween 20 11.5±0.2 11.0±0.2 10.7±0.4 10.8±0.5 10,6±0.7
H2O 12.7±0.7 11.5±0.1 10.6±0.5 11.0±0.9 10.8±0.8
Data are presented as means ± SE (n = 10). *p< 0.05, ** p<0.01, *** p<0.001, **** p<0.0001 compared to time 0; # p<0.05, 
## p<0.01, ### p<0.001, #### p<0.0001 compared to placebo group at the same time point.
Extracts improved glucose tolerance in glucose-challenged mice 
The extracts identified to have glucose lowering effect in screening evaluation were further tested in 
the OGTT. Among the pseudocereals, the AC EtOH70 extract (2000 mg/kg b.w.) improved the glucose 
tolerance (Figure 1A - 1B). The effect was dose-dependent and comparable to that of glibenclamide (0.5 
mg/kg b.w.). The CQ EtOH70 extract (2000 mg/kg b.w.) improved also glucose tolerance compared to 
the placebo (Figure 1C - 1D).
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Figure 1. Effect of pseudocereals on glycemia levels during OGTT performed in fasted mice. Male Swiss mice (20 ± 
5g), fasted for 12 h received AC (A), CQ (C) and CP (E) EtOH70 extracts, one hour before glucose-challenge, 
and glycemia was determined at 0, 15, 30, 60 and 120 min. The area under the curve was calculated from 
time 0 to 120 min for AC (B), CQ (D) and for CP (F). Data are presented as means ± SE (n = 10). *p< 0.05, ** 
p<0.01, *** p<0.001, **** p<0.0001 compared to placebo group.
Both CP (Figure 1E – 1F) and LM (Figure 2A – 2B) EtOH70 extracts improved glucose tolerance in specific 
time points after glucose challenge, but CP effect was not of enough magnitude to decrease the AUC 
of glucose.
Figure 2. Effect of LM on glycemia levels during OGTT in fasted mice. Male Swiss mice (20 ± 5g) fasted for 12 h re-
ceived LM EtOH70 extract (A) one hour before the OGTT and glycemia was determined at 0, 15, 30, 60 and 
120 min. The area under the curve was calculated from time 0 to 120 min (B). Data are presented as means 
± SE (n = 10). *p< 0.05, ** p<0.01, *** p<0.001, **** p<0.0001 compared to placebo group.
Finally, the SS EtOH70 extract (1000 mg/kg b.w.) improved the glucose tolerance in a dose-dependent 
manner (Figure 3A - 3B).
LM, AC and CQ EtOH70 extracts stimulate islets insulin secretion 
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Active extracts stimulated the in vitro insulin secretion in high glucose conditions (16.7 mM) by expo-
sure to AC EtOH70 extract (Figure 4A), CQ EtOH70 extract (Figure 4 B) and LM EtOH70 extract (Figure 4 C) 
in concentration-dependent manner. 
Figure 3. Effect of SS on glucose levels during OGTT in fasted mice. Male Swiss mice (20 ± 5g) fasted for 12 h received 
SS EtOH70 extract (A) one hour before OGTT and glycemia was determined at 0, 15, 30, 60 and 120 min. 
The area under the curve was calculated from time 0 to 120 min (B). Data are presented as means ± SE 
(n = 10). *p< 0.05, ** p<0.01, *** p<0.001, **** p<0.0001 compared to placebo group.
Figure 4. Effect of LM, CQ and AC on islets insulin secretion. The insulin secretion was evaluated in Swiss mice is-
lets cultured at low (3.3 mM) and high (16.7 mM) glucose in presence of EtOH70 extracts of LM (5, 10 and 
20 mg/ml) (A), CQ (5, 10 and 20 mg/ml) (B) and AC (10, 15 and 20 mg/ml) (C). Insulin concentration was 
measured by ELISA. The data are presented as means ± SE (n = 3), of duplicates from three independent 
experiments. *p< 0.05, ** p<0.01, *** p<0.001, **** p<0.0001 compared to negative control.
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Discussion
Our results show that AC, CQ, CP, LM and SS have glycemia reducing effect in both non-fasted and in 
glucose-challenged mice. The effect was comparable to that of glibenclamide. Moreover, we show that 
the glucose-reducing effect of LM, CQ and AC is at least partially explained by the stimulation of insulin 
secretion. 
Three kinds of extracts of each plant species were evaluated. During both, screening and OGTT exper-
iments, in healthy animals; the EtOH70 extracts of AC, CQ, LM and SS showed major and significant 
glucose-reducing effect. Additionally, a slight but significant effect was found in for CP EtOH70 and CQ 
Aq extract. OGTT was performed with EtOH70 extracts, the most active ones. Extract preparation is an 
important factor that should be considered to assess the plant effects. If the purpose is to mimic the 
way that the plant is consumed, for the studied plants, the aqueous extract is the closest way to its use. 
However, we found that a mixture of water with ethanol enrich the extract with organic compounds, 
which are responsible for the effect. 
The qualitative phytochemical analysis performed with EtOH70 extracts confirmed previous reports by 
identifying phenolic acids, and flavonoids for andean indigenous grains (AC, CQ and CP)(28,30) and alka-
loids for LM(29,15). For SS we found the presence of anthocyanidins, coumarins and phenolic compounds, 
constituents also previously reported(21). 
The toxicity studies of EtOH70 extracts, were performed considering the OECD guidelines, that suggest 
to treat animals with doses equal or lower than 2000 mg/kg b.w. None of the EtOH70 extracts showed 
acute toxic effects; in vitro evaluation established parameters of safe concentrations. However, further 
evaluations need to be performed regarding possible sub-acute and chronic toxicity effect.
Amaranthus caudatus (AC) is a pseudocereal native of the andean Bolivian region. Its seeds are usually 
consumed in beverages, foods such soups or bread or as toasted flour(31). Traditional medicine proper-
ties attributed to AC are “blood purifier”, diuretic, and “digestive”(32). Methanol extract of AC leaves has 
been reported to exert anti-diabetic activity in rats with streptozotocin (STZ)-induced diabetes(33). Ad-
ditionally, AC seeds inhibited α-amylase(34) and showed significant antioxidant activity(20). In a previous 
study, using a non-obese diabetic model the Goto-kakisaki (GK) rats, the EtOH70 extract of AC improved 
the glucose tolerance(17,28); in the present study our results confirm the glycemia-reducing effect for the 
seeds (EtOH70 extract) both in non-fasting mice as well during OGTT. 
Chenopodium quinoa (CQ) seeds are also used in food preparations as a part of the diet of rural Bolivian 
families, including a variety of soups and refreshments(35). Phenolic compounds responsible for the 
antioxidative activity represent the nutraceutical potential of CQ(36,37). In addition, CQ inhibits α-glucosi-
dase with no effect on pancreatic α–amylase(9). In high fructose-treated Wistar rats, CQ reduced most of 
the adverse effects exerted by fructose on lipid profile and glycemia(38). Our results confirmed the gly-
cemia-reducing properties of CQ, for all kinds of extracts evaluated which improved the glucose levels 
both in non-fasting animals and during glucose-challenged mice. 
Lupinus mutabilis (LM) seeds are usually consumed as washed and cooked seeds. The washing pro-
cedure abolishes the spicy taste that is attributed to the content in alkaloids(15). To reduce glycemia in 
patients with diabetes the traditional use is to drink the water in which the seeds were washed(39). It has 
been reported that LM decreases glycemia in patients with intolerance to glucose(16), and in patients 
with type 2 diabetes due to the alkaloid content(15). For this purpose we used unwashed seeds with high 
alkaloid content that has been claimed to be active component. Furthermore, were did not cooked the 
seeds to preserve labile components. In a previous study we found that LM EtOH70 extract improves 
glucose tolerance in diabetic GK rats(29). In this study we confirmed the effect of LM EtOH70 on the glu-
cose tolerance, effect that could be attributed to its alkaloids content.
Smallanthus sonchifolius (SS) root is consumed in rural valley regions where is well known for their 
properties to reduce weight(40), due to their high content of components that cannot be digested (inu-
lin and fructooligosacharides)(13,41,42). Our findings showed also glycemia-reducing effect in non-fasting 
animals and glucose-challenged mice. 
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Chenopodium pallidicaule (CP) seeds are usually consumed in soups and refreshments(12).CP antioxi-
dant properties and composition is closely related to CQ and AC as they belong from the same fami-
ly(30,43,44). In our evaluations, the extracts show a glycemia-reducing effect both during screening eval-
uations and during the glucose-challenged model that warrants further studies on the nutraceutical 
potential of CP. 
To explore the mechanism behind the glycemia-reducing effect found in animals, experiments of in-
sulin secretion by mice islets were performed in the presence of active EtOH70 extracts. AC promoted 
insulin secretion at high glucose (16.7 mM) but not at low (3.3 mM) glucose levels which is ideal for a 
potential therapeutic use, similar results to the previous findings(17,28). CQ and LM stimulated insulin se-
cretion however in both low and high glucose and these effects were concentration-dependent, effect 
similar with sulphonylurea drugs that have been used for decades for treatment of diabetes. LM effect 
seems to be non-glucose dependent, findings that could induce a hypoglycemic state. However, similar 
results were found in GK rats, where LM did not exert hypoglycemia(17,29). No effect on insulin secretion 
was found for CP and SS (data not shown); it is therefore important to further explore their effect on 
the insulin sensitivity or glucose absorption since they exhibit clear effects on glycemia. The concentra-
tions evaluated for all the extracts were below the CC50 found in cell cultures for 24 h. 
Conclusion
We provide information about the glycemia-reducing properties of Bolivian food plants Amaranthus 
caudatus, Chenopodium quinoa, Chenopodium pallidicaule, Lupinus mutabilis and Smallanthus sonchi-
folius that exhibit glucose lowering effect, while only Amaranthus caudatus, Chenopodium quinoa and 
Lupinus mutabilis stimulate directly the insulin secretion. All studied plants are potential nutraceuticals 
for improving the glycemia when needed.
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